Literature DB >> 16946151

Increased balloon-induced inflammation, proliferation, and neointima formation in apolipoprotein E (ApoE) knockout mice.

Christian M Matter1, Liming Ma, Tobias von Lukowicz, Patricia Meier, Christine Lohmann, Dongming Zhang, Ulkan Kilic, Eugen Hofmann, Suk-Woo Ha, Martin Hersberger, Dirk M Hermann, Thomas F Lüscher.   

Abstract

BACKGROUND AND
PURPOSE: The pathophysiology of vascular lesions after balloon angioplasty remains poorly understood. A major limitation of most experimental studies in this regard is that injury was assessed in healthy arteries. Our aim was to study the effects of hypercholesterolemia in a mouse vascular injury model that mimics human balloon angioplasty.
METHODS: Carotid balloon distension was performed in wild-type (WT) mice on a normal diet (ND), in apolipoprotein E-deficient (ApoE-/-) mice on ND and in ApoE-/- mice fed a high cholesterol diet (CD).
RESULTS: Medial cell death (TUNEL) was elevated in all mice at 1 hour and 1 day after angioplasty without differences between the groups. We found enhanced intimal inflammation (%CD45-positive cells) and vascular cell adhesion molecule-1 expression at 7 days (P < 0.05; n > or = 4) as well as increased proliferation rates (BrdU-index) in ApoE-/- CD at 7 and 28 days postinjury (P < 0.05; n > or = 5). Four weeks after injury, these events led to enhanced neointima in ApoE-/- CD compared with WT ND mice (intima/media, P < 0.001; n > or = 8). The amount of lesion formation paralleled the incremental increase in total plasma cholesterol in WT ND, ApoE-/- ND and ApoE-/- CD (P < 0.01).
CONCLUSIONS: Carotid balloon distension injury in ApoE-/- mice on CD induced enhanced inflammation and proliferation leading to increased neointima. Further applications of this microballoon catheter in genetically modified mice will provide opportunities to elucidate molecular mechanisms of vascular lesion formation in a model that reflects clinical balloon angioplasty. This know-how may pave the way to catheter-based interventions of human microvessels in the peripheral or cerebral circulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16946151     DOI: 10.1161/01.STR.0000241068.50156.82

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  14 in total

1.  Ginsenoside Rb1 attenuates homocysteine-augmented guidewire injury-induced intimal hyperplasia in mice.

Authors:  Hong Chai; Yanlan Dong; Xinwen Wang; Wei Zhou
Journal:  J Surg Res       Date:  2008-08-15       Impact factor: 2.192

2.  Disruption of platelet-derived growth factor-dependent phosphatidylinositol 3-kinase and phospholipase Cγ 1 activity abolishes vascular smooth muscle cell proliferation and migration and attenuates neointima formation in vivo.

Authors:  Evren Caglayan; Marius Vantler; Olli Leppänen; Felix Gerhardt; Lenard Mustafov; Henrik Ten Freyhaus; Kai Kappert; Margarete Odenthal; Wolfram H Zimmermann; Michelle D Tallquist; Stephan Rosenkranz
Journal:  J Am Coll Cardiol       Date:  2011-06-21       Impact factor: 24.094

3.  In vivo assessment of the effects of ginsenoside Rb1 on intimal hyperplasia in ApoE knockout mice.

Authors:  Hong Chai; Geoff Schultz; Kamran Aghaie; Wei Zhou
Journal:  J Surg Res       Date:  2010-02-11       Impact factor: 2.192

4.  Oxidized low-density lipoprotein decreases VEGFR2 expression in HUVECs and impairs angiogenesis.

Authors:  Min Zhang; Li Jiang
Journal:  Exp Ther Med       Date:  2016-10-19       Impact factor: 2.447

5.  Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta.

Authors:  Grigol Tediashvili; Dong Wang; Hermann Reichenspurner; Tobias Deuse; Sonja Schrepfer
Journal:  J Vis Exp       Date:  2018-02-07       Impact factor: 1.355

6.  Early hypercholesterolemia contributes to vasomotor dysfunction and injury associated atherogenesis that can be inhibited by nitric oxide.

Authors:  Kathleen G Raman; Robin E Gandley; Jennifer Rohland; Mazen S Zenati; Edith Tzeng
Journal:  J Vasc Surg       Date:  2010-12-15       Impact factor: 4.268

7.  Cannabinoid receptor CB2 protects against balloon-induced neointima formation.

Authors:  Filippo Molica; Christian M Matter; Fabienne Burger; Graziano Pelli; Sébastien Lenglet; Andreas Zimmer; Pal Pacher; Sabine Steffens
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-06       Impact factor: 4.733

8.  Endogenous cannabinoid receptor CB1 activation promotes vascular smooth-muscle cell proliferation and neointima formation.

Authors:  Filippo Molica; Fabienne Burger; Aurélien Thomas; Christian Staub; Anne Tailleux; Bart Staels; Graziano Pelli; Andreas Zimmer; Benjamin Cravatt; Christian M Matter; Pal Pacher; Sabine Steffens
Journal:  J Lipid Res       Date:  2013-03-11       Impact factor: 5.922

9.  Sympathetic nervous system-targeted neuropeptide Y overexpression in mice enhances neointimal formation in response to vascular injury.

Authors:  Suvi T Ruohonen; Ken Abe; Mia Kero; Laura Toukola; Saku Ruohonen; Matias Röyttä; Markku Koulu; Ullamari Pesonen; Zofia Zukowska; Eriika Savontaus
Journal:  Peptides       Date:  2008-12-24       Impact factor: 3.750

10.  Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening.

Authors:  Devashish Kothapalli; Shu-Lin Liu; Yong Ho Bae; James Monslow; Tina Xu; Elizabeth A Hawthorne; Fitzroy J Byfield; Paola Castagnino; Shilpa Rao; Daniel J Rader; Ellen Puré; Michael C Phillips; Sissel Lund-Katz; Paul A Janmey; Richard K Assoian
Journal:  Cell Rep       Date:  2012-10-25       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.